Hunan Fangsheng Pharmaceutical Co., Ltd.SSE: 603998

Announcement on Outline of Investor Reception Day

· Issued by Hunan Fangsheng Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 8 pages · Chinese

Summary by 6ix AI

The event aims to provide insights into the company's new product, a traditional Chinese medicine for treating tension-type headaches, which has recently been included in the national medical insurance list. Company executives and industry experts will participate, discussing the company's strategic plans and product development. The announcement emphasizes the company's commitment to innovation in traditional Chinese medicine and its future growth prospects.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Hunan Fangsheng Pharmaceutical Co., Ltd. on 6ix

Earlier from Hunan Fangsheng Pharmaceutical

Later from Hunan Fangsheng Pharmaceutical

All Hunan Fangsheng Pharmaceutical news releases